Japanese multicenter phase II and pharmacokinetic study of rituximab in relapsed or refractory patients with aggressive B-cell lymphoma (Q44865302)

From Wikidata
Jump to navigation Jump to search
scientific article published in May 2004
edit
Language Label Description Also known as
English
Japanese multicenter phase II and pharmacokinetic study of rituximab in relapsed or refractory patients with aggressive B-cell lymphoma
scientific article published in May 2004

    Statements

    Japanese multicenter phase II and pharmacokinetic study of rituximab in relapsed or refractory patients with aggressive B-cell lymphoma (English)
    IDEC-C2B8 Japan Study Group

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit